Bartiromo, Marilù

Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19). [electronic resource] - Transplant infectious disease : an official journal of the Transplantation Society Aug 2020 - e13286 p. digital

Publication Type: Case Reports; Journal Article

1399-3062

10.1111/tid.13286 doi


Adult
Antiviral Agents--adverse effects
Betacoronavirus
C-Reactive Protein--immunology
COVID-19
Ciliopathies--complications
Cobicistat--therapeutic use
Common Cold--etiology
Coronavirus Infections--complications
Cough--etiology
Cytochrome P-450 CYP3A Inhibitors--adverse effects
Darunavir--therapeutic use
Deprescriptions
Drug Combinations
Drug Interactions
Enzyme Inhibitors--therapeutic use
Fatigue--etiology
Female
Glucocorticoids--therapeutic use
Graft Rejection--prevention & control
Humans
Hydroxychloroquine--therapeutic use
Immunocompromised Host--immunology
Immunosuppressive Agents--adverse effects
Interleukin-10--immunology
Interleukin-1beta--immunology
Interleukin-6--immunology
Interleukin-8--immunology
Kidney Diseases, Cystic--complications
Kidney Failure, Chronic--etiology
Kidney Transplantation
Leber Congenital Amaurosis--complications
Lopinavir--adverse effects
Methylprednisolone--therapeutic use
Optic Atrophies, Hereditary--complications
Pandemics
Pneumonia, Viral--complications
Ritonavir--adverse effects
SARS-CoV-2
Severity of Illness Index
Tacrolimus--adverse effects
COVID-19 Drug Treatment